Hypertension and 10-year risk of coronary artery diseases in adult population: Yazd healthy heart project

Document Type : Original Article

Authors

1 Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Physical Medicine & Rehabilitation, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Department of Medicine, Yazd Branch, Islamic Azad University, Yazd, Iran

4 Department of Internal Medicine, BH10-642, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland

5 Department of Health Sciences, Bielefeld University, Bielefeld, Germany

6 Clinical Research Development Center, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

7 Department of Occupational Health Engineering, Genetic and Environmental Adventures Research Center, School of Abarkouh Medical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

8 Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

10.48305/arya.2025.45949.3127
Abstract
BACKGROUND: The incidence of coronary artery disease (CAD) is influenced by several risk factors, including hypertension. Although the association between hypertension and CAD has been investigated in Western countries, limited research has been conducted in Asia and the Middle East. We investigated the association between hypertension and the 10‑year risk of CAD in the adult population.
METHODS: In this cohort study, 2,000 participants aged 20 to 74 years in the Yazd Healthy Heart Project were enrolled in 2005–2006 and followed up to 2015–2016. Participants with a history of CAD were excluded. At baseline, data on demographic characteristics, anthropometric measurements, biochemical blood tests, and lifestyle factors were collected. The association between hypertension and approximately 10‑year CAD risk was assessed using the Cox regression model.
RESULTS: The baseline prevalence of hypertension among adults was 36.1%. During the ten‑year follow‑up, CAD incidence was 16.8% in men, 12.0% in women, and 14.5% in the total population. After adjusting for potential confounders, hypertension increased the risk of CAD in men (HR = 1.64; 95% CI: 1.09–2.46), women (HR = 2.16; 95% CI: 1.15–4.05), and the whole sample (HR = 1.73; 95% CI: 1.23–2.43). This association was similar in men and women (p for interaction ≥0.05).
CONCLUSION: This study demonstrated a significant association between hypertension and CAD risk, highlighting the need for targeted interventions in populations with hypertension to reduce CAD risk.

Keywords


1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM,, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010
2. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016 Jul;4(13):256. https://doi.org/10.21037/atm.2016.06.33
3. Stark B, Johnson C, Roth GA. Global prevalence of coronary artery disease: update from the Global Burden of Disease Study. J Am Coll Cardiol. 2024;83(13 Suppl):2320.
4. Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart Views. 2017 Jul-Sep;18(3):109-14. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17
5. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, et al. Treatment of hypertension in patients with coronary artery disease. J Am Coll Cardiol. 2015;65(18):1998-2038. https://doi.org/10.1016/j.jacc.2015.02.038
6. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47. https://doi.org/10.1016/s2213-8587(14)70102-0
7. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. https://doi.org/10.1038/s41581-019-0244-2
8. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control. Curr Hypertens Rep. 2019 Apr 4;21(4):27. https://doi.org/10.1007/s11906-019-0933-z
9. Mohammadi S, Hassanipour S, Delam H, Nikbakht H-A, Far ZG, Firoozi D, et al. Prevalence of hypertension in Iran: An updated systematic review and meta-analysis of community-based studies. Caspian J Intern Med. 2023 Autumn;14(4):607–17. https://doi.org/10.22088/cjim.14.43.607
10. Milane A, Abdallah J, Kanbar R, Khazen G, Ghassibe-Sabbagh M, Salloum AK, et al. Association of hypertension with coronary artery disease onset in the Lebanese population. Springerplus. 2014 Sep 16;3:533. https://doi.org/10.1186/2193-1801-3-533
11. Cubrilo-Turek M. Hypertension and Coronary Heart Disease. EJIFCC. 2003 Jul 3;14(2):67-73.
12. SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. https://doi.org/10.1056/nejmoa1511939
13. Gu D, Kelly TN, Wu X, Chen J, Duan X, Huang J-F, et al. Blood pressure and risk of cardiovascular disease in Chinese men and women. Am J Hypertens. 2008 Mar;21(3):265-72. https://doi.org/10.1038/ajh.2007.59
14. Weber T, Lang I, Zweiker R, Horn S, Wenzel RR, Watschinger B, et al. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations: A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension. Wien Klin Wochenschr. 2016 Jul;128(13-14):467-79. https://doi.org/10.1007/s00508-016-0998-5
15. Sarebanhassanabadi M, Mirjalili SR, Marques-Vidal P, Kraemer A, Namayandeh SM. Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study. BMC Cardiovasc Disord. 2024 Feb 12;24(1):101. https://doi.org/10.1186/s12872-024-03769-3
16. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009 Mar;31(1):47-58. https://doi.org/10.1093/pubmed/fdn078
17. Jaddou HY, Batieha AM, Khader YS, Kanaan AH, El-Khateeb MS, Ajlouni KM. Hypertension prevalence, awareness, treatment and control, and associated factors: results from a national survey, jordan. Int J Hypertens. 2011;2011:828797. https://doi.org/10.4061/2011/828797
18. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U. Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol. 2007 Sep;17(9):713-20. https://doi.org/10.1016/j.annepidem.2007.03.016
19. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002 Nov 2;360(9343):1347-60. https://doi.org/10.1016/s0140-6736(02)11403-6
20. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (London, England). 2002;360(9349):1903-13. https://doi.org/10.1016/S0140-6736(02)11911-8
21. Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis. JAMA Cardiol. 2017 Jul 1;2(7):775-81. https://doi.org/10.1001/jamacardio.2017.1421
22. Zeina AR, Barmeir E, Zaid G, Odeh M. Coronary artery disease among hypertensive patients undergoing coronary computed tomography angiography. J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):252-6. https://doi.org/10.2459/jcm.0b013e3283240486
23. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001 Dec 4;104(23):2855-64. https://doi.org/10.1161/hc4701.099488
24. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016 Mar 5;387(10022):957-67. https://doi.org/10.1016/S0140-6736(15)01225-8
25. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 May 12;97(18):1837-47. https://doi.org/10.1161/01.cir.97.18.1837
26. Zafari N, Asgari S, Lotfaliany M, Hadaegh A, Azizi F, Hadaegh F. Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Sci Rep. 2017;7(1):14220. https://doi.org/10.1038/s41598-017-14631-2
27. Mitsutake R, Miura S, Shiga Y, Uehara Y, Saku K. Association between hypertension and coronary artery disease as assessed by coronary computed tomography. J Clin Hypertens (Greenwich). 2011 Mar;13(3):198-204. https://doi.org/10.1111/j.1751-7176.2010.00412.x
28. Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, et al. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012 Sep;35(9):947-53. https://doi.org/10.1038/hr.2012.87
29. Najafi M, Sheikhvatan M. Gender differences in coronary artery disease: correlational study on dietary pattern and known cardiovascular risk factors. Int Cardiovasc Res J. 2013 Dec;7(4):124-9.
30. Abbasi SH, Kassaian SE. Women and coronary artery disease. Part I: basic considerations. J Tehran Heart Cent. 2011 Summer;6(3):109-16.